Use and Misuse of Cardiac Troponins in Clinical Practice

Progress in Cardiovascular Diseases

Volumn 50, Issue 2, 2007, Pages 151-165

  Gupta, Sachin ^a   de Lemos, James A ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTITHROMBOCYTIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BIOLOGICAL MARKER; CREATINE KINASE; DALTEPARIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; PLACEBO; TROPONIN;

ACUTE CORONARY SYNDROME; ACUTE HEART INFARCTION; ANGINA PECTORIS; ARTICLE; CLINICAL TRIAL; CONGESTIVE HEART FAILURE; CONTROLLED CLINICAL TRIAL; CORONARY ARTERY DISEASE; DIAGNOSTIC ACCURACY; ELECTROCARDIOGRAM; HEART INFARCTION; HEART INJURY; HEART MUSCLE INJURY; HUMAN; MEDICAL PRACTICE; MEDICAL RESEARCH; META ANALYSIS; MORTALITY; PROGNOSIS; RESUSCITATION; SENSITIVITY AND SPECIFICITY; SEPSIS; SYSTEMATIC REVIEW;

BIOLOGICAL MARKERS; HUMANS; MYOCARDIAL INFARCTION; PREDICTIVE VALUE OF TESTS; TROPONIN;

EID: 34548294295     PISSN: 00330620     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pcad.2007.01.002     Document Type: Article

References (158)

1. Lindsell C.J., Anantharaman V., Diercks D., et al. The Internet Tracking Registry of Acute Coronary Syndromes (i*trACS): a multicenter registry of patients with suspicion of acute coronary syndromes reported using the standardized reporting guidelines for emergency department chest pain studies. Ann Emerg Med 48 (2006) 666-677
2. James S.K., Lindahl B., Siegbahn A., et al. N-terminal pro-brain natriuretic peptide and other risk markers for the separate prediction of mortality and subsequent myocardial infarction in patients with unstable coronary artery disease: a Global Utilization of Strategies To Open occluded arteries (GUSTO)-IV substudy. Circulation 108 (2003) 275-281
3. Morrow D.A., and Braunwald E. Future of biomarkers in acute coronary syndromes: moving toward a multimarker strategy. Circulation 108 (2003) 250-252
4. de Lemos J.A., and Morrow D.A. Combining natriuretic peptides and necrosis markers in the assessment of acute coronary syndromes. Rev Cardiovasc Med 4 Suppl 4 (2003) S37-S46
5. Apple F.S. Tissue specificity of cardiac troponin I, cardiac troponin T and creatine kinase-MB. Clin Chim Acta 284 (1999) 151-159
6. Imazio M., Demichelis B., Cecchi E., et al. Cardiac troponin I in acute pericarditis. J Am Coll Cardiol 42 (2003) 2144-2148
7. Yazici Y., and Kagen L.J. Cardiac involvement in myositis. Curr Opin Rheumatol 14 (2002) 663-665
8. Mahrholdt H., Wagner A., Deluigi C.C., et al. Presentation, patterns of myocardial damage, and clinical course of viral myocarditis. Circulation 114 (2006) 1581-1590
9. Mahajan N., Mehta Y., Rose M., et al. Elevated troponin level is not synonymous with myocardial infarction. Int J Cardiol 111 (2006) 442-449
10. Alpert J.S., Thygesen K., Antman E., et al. Myocardial infarction redefined-a consensus document of The Joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial infarction. J Am Coll Cardiol 36 (2000) 959-969
11. Kavsak P.A., MacRae A.R., Lustig V., et al. The impact of the ESC/ACC redefinition of myocardial infarction and new sensitive troponin assays on the frequency of acute myocardial infarction. Am Heart J 152 (2006) 118-125
12. Newby L.K., Kaplan A.L., Granger B.B., et al. Comparison of cardiac troponin T versus creatine kinase-MB for risk stratification in a chest pain evaluation unit. Am J Cardiol 85 (2000) 801-805
13. Kontos M.C., Anderson F.P., Alimard R., et al. Ability of troponin I to predict cardiac events in patients admitted from the emergency department. J Am Coll Cardiol 36 (2000) 1818-1823
14. Kontos M.C., Jesse R.L., Anderson F.P., et al. Comparison of myocardial perfusion imaging and cardiac troponin I in patients admitted to the emergency department with chest pain. Circulation 99 (1999) 2073-2078
15. de Winter R.J. Risk stratification with cardiac troponin I in acute coronary syndromes. J Am Coll Cardiol 36 (2000) 1824-1826
16. Bertrand M.E., Simoons M.L., Fox K.A., et al. Management of acute coronary syndromes: acute coronary syndromes without persistent ST segment elevation; recommendations of the Task Force of the European Society of Cardiology. Eur Heart J 21 (2000) 1406-1432
17. Braunwald E., Antman E.M., Beasley J.W., et al. ACC/AHA 2002 guideline update for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction-summary article: a report of the American College of Cardiology/American Heart Association task force on practice guidelines (Committee on the Management of Patients With Unstable Angina). J Am Coll Cardiol 40 (2002) 1366-1374
18. Antman E.M. Decision making with cardiac troponin tests. N Engl J Med 346 (2002) 2079-2082
19. Wallace T.W., Abdullah S.M., Drazner M.H., et al. Prevalence and determinants of troponin T elevation in the general population. Circulation 113 (2006) 1958-1965
20. Kontos M.C., Garg R., Anderson F.P., et al. Outcomes in patients admitted for chest pain with renal failure and troponin I elevations. Am Heart J 150 (2005) 674-680
21. McCord J., Nowak R.M., McCullough P.A., et al. Ninety-minute exclusion of acute myocardial infarction by use of quantitative point-of-care testing of myoglobin and troponin I. Circulation 104 (2001) 1483-1488
22. Hamm C.W., Goldmann B.U., Heeschen C., et al. Emergency room triage of patients with acute chest pain by means of rapid testing for cardiac troponin T or troponin I. N Engl J Med 337 (1997) 1648-1653
23. Newby L.K., Storrow A.B., Gibler W.B., et al. Bedside multimarker testing for risk stratification in chest pain units: the chest pain evaluation by creatine kinase-MB, myoglobin, and troponin I (CHECKMATE) study. Circulation 103 (2001) 1832-1837
24. Collinson P.O., John C., Lynch S., et al. A prospective randomized controlled trial of point-of-care testing on the coronary care unit. Ann Clin Biochem 41 (2004) 397-404
25. Hamm C.W. Cardiac biomarkers for rapid evaluation of chest pain. Circulation 104 (2001) 1454-1456
26. Koukkunen H., Penttila K., Kemppainen A., et al. Differences in the diagnosis of myocardial infarction by troponin T compared with clinical and epidemiologic criteria. Am J Cardiol 88 (2001) 727-731
27. Salomaa V., Koukkunen H., Ketonen M., et al. A new definition for myocardial infarction: what difference does it make?. Eur Heart J 26 (2005) 1719-1725
28. Oltrona L., Ottani F., and Galvani M. Clinical significance of a single measurement of troponin-I and C-reactive protein at admission in 1773 consecutive patients with acute coronary syndromes. Am Heart J 148 (2004) 405-415
29. Morrow D.A., Antman E.M., Tanasijevic M., et al. Cardiac troponin I for stratification of early outcomes and the efficacy of enoxaparin in unstable angina: a TIMI-11B substudy. J Am Coll Cardiol 36 (2000) 1812-1817
30. James S.K., Armstrong P., Barnathan E., et al. Troponin and C-reactive protein have different relations to subsequent mortality and myocardial infarction after acute coronary syndrome: a GUSTO-IV substudy. J Am Coll Cardiol 41 (2003) 916-924
31. Newby L.K., Christenson R.H., Ohman E.M., et al. Value of serial troponin T measures for early and late risk stratification in patients with acute coronary syndromes. The GUSTO-IIa Investigators. Circulation 98 (1998) 1853-1859
32. Kleiman N.S., Lakkis N., Cannon C.P., et al. Prospective analysis of creatine kinase muscle-brain fraction and comparison with troponin T to predict cardiac risk and benefit of an invasive strategy in patients with non-ST-elevation acute coronary syndromes. J Am Coll Cardiol 40 (2002) 1044-1050
33. Morrow D.A., Rifai N., Tanasijevic M.J., et al. Clinical efficacy of three assays for cardiac troponin I for risk stratification in acute coronary syndromes: a Thrombolysis In Myocardial Infarction (TIMI) 11B Substudy. Clin Chem 46 (2000) 453-460
34. Hamm C.W., Ravkilde J., Gerhardt W., et al. The prognostic value of serum troponin T in unstable angina. N Engl J Med 327 (1992) 146-150
35. Norgaard B.L., Andersen K., Thygesen K., et al. Long-term risk stratification of patients with acute coronary syndromes: characteristics of troponin T testing and continuous ST segment monitoring. Heart 90 (2004) 739-744
36. James S., Armstrong P., Califf R., et al. Troponin T levels and risk of 30-day outcomes in patients with the acute coronary syndrome: prospective verification in the GUSTO-IV trial. Am J Med 115 (2003) 178-184
37. Mueller C., Neumann F.J., Perruchoud A.P., et al. Prognostic value of quantitative troponin T measurements in unstable angina/non-ST-segment elevation acute myocardial infarction treated early and predominantly with percutaneous coronary intervention. Am J Med 117 (2004) 897-902
38. Henrikson C.A., Howell E.E., Bush D.E., et al. Prognostic usefulness of marginal troponin T elevation. Am J Cardiol 93 (2004) 275-279
39. Lindahl B., Venge P., and Wallentin L. Relation between troponin T and the risk of subsequent cardiac events in unstable coronary artery disease. The FRISC study group. Circulation 93 (1996) 1651-1657
40. Hamm C.W., Heeschen C., Goldmann B., et al. Benefit of abciximab in patients with refractory unstable angina in relation to serum troponin T levels. c7E3 Fab Antiplatelet Therapy in Unstable Refractory Angina (CAPTURE) Study Investigators. N Engl J Med 340 (1999) 1623-1629
41. Ohman E.M., Armstrong P.W., Christenson R.H., et al. Cardiac troponin T levels for risk stratification in acute myocardial ischemia. GUSTO IIA Investigators. N Engl J Med 335 (1996) 1333-1341
42. Sayre M.R., Kaufmann K.H., Chen I.W., et al. Measurement of cardiac troponin T is an effective method for predicting complications among emergency department patients with chest pain. Ann Emerg Med 31 (1998) 539-549
43. deFilippi C.R., Tocchi M., Parmar R.J., et al. Cardiac troponin T in chest pain unit patients without ischemic electrocardiographic changes: angiographic correlates and long-term clinical outcomes. J Am Coll Cardiol 35 (2000) 1827-1834
44. Ottani F., Galvani M., Nicolini F.A., et al. Elevated cardiac troponin levels predict the risk of adverse outcome in patients with acute coronary syndromes. Am Heart J 140 (2000) 917-927
45. Aviles R.J., Askari A.T., Lindahl B., et al. Troponin T levels in patients with acute coronary syndromes, with or without renal dysfunction. N Engl J Med 346 (2002) 2047-2052
46. Mega J.L., Morrow D.A., Sabatine M.S., et al. Correlation between the TIMI risk score and high-risk angiographic findings in non-ST-elevation acute coronary syndromes: observations from the Platelet Receptor Inhibition in Ischemic Syndrome Management in Patients Limited by Unstable Signs and Symptoms (PRISM-PLUS) trial. Am Heart J 149 (2005) 846-850
47. Wong G.C., Morrow D.A., Murphy S., et al. Elevations in troponin T and I are associated with abnormal tissue level perfusion: a TACTICS-TIMI 18 substudy. Treat Angina with Aggrastat and Determine Cost of Therapy with an Invasive or Conservative Strategy-Thrombolysis in Myocardial Infarction. Circulation 106 (2002) 202-207
48. Lindahl B., Diderholm E., Lagerqvist B., et al. Mechanisms behind the prognostic value of troponin T in unstable coronary artery disease: a FRISC II substudy. J Am Coll Cardiol 38 (2001) 979-986
49. Jurlander B., Farhi E.R., Banas Jr. J.J., et al. Coronary angiographic findings and troponin T in patients with unstable angina pectoris. Am J Cardiol 85 (2000) 810-814
50. Okamatsu K., Takano M., Sakai S., et al. Elevated troponin T levels and lesion characteristics in non-ST-elevation acute coronary syndromes. Circulation 109 (2004) 465-470
51. Ohtani T., Ueda Y., Shimizu M., et al. Association between cardiac troponin T elevation and angioscopic morphology of culprit lesion in patients with non-ST-segment elevation acute coronary syndrome. Am Heart J 150 (2005) 227-233
52. Dokainish H., Pillai M., Murphy S.A., et al. Prognostic implications of elevated troponin in patients with suspected acute coronary syndrome but no critical epicardial coronary disease: a TACTICS-TIMI-18 substudy. J Am Coll Cardiol 45 (2005) 19-24
53. Lindahl B., Venge P., and Wallentin L. Troponin T identifies patients with unstable coronary artery disease who benefit from long-term antithrombotic protection. Fragmin in Unstable Coronary Artery Disease (FRISC) Study Group. J Am Coll Cardiol 29 (1997) 43-48
54. de Lemos J.A., Blazing M.A., Wiviott S.D., et al. Enoxaparin versus unfractionated heparin in patients treated with tirofiban, aspirin and an early conservative initial management strategy: results from the A phase of the A-to-Z trial. Eur Heart J 25 (2004) 1688-1694
55. Gibson C.M., de Lemos J.A., Murphy S.A., et al. Combination therapy with abciximab reduces angiographically evident thrombus in acute myocardial infarction: a TIMI 14 substudy. Circulation 103 (2001) 2550-2554
56. Newby L.K., Ohman E.M., Christenson R.H., et al. Benefit of glycoprotein IIb/IIIa inhibition in patients with acute coronary syndromes and troponin t-positive status: the paragon-B troponin T substudy. Circulation 103 (2001) 2891-2896
57. Heeschen C., Hamm C.W., Goldmann B., et al. Troponin concentrations for stratification of patients with acute coronary syndromes in relation to therapeutic efficacy of tirofiban. PRISM Study Investigators. Platelet Receptor Inhibition in Ischemic Syndrome Management. Lancet 354 (1999) 1757-1762
58. Kastrati A., Mehilli J., Neumann F.J., et al. Abciximab in patients with acute coronary syndromes undergoing percutaneous coronary intervention after clopidogrel pretreatment: the ISAR-REACT 2 randomized trial. JAMA 295 (2006) 1531-1538
59. Morrow D.A., Cannon C.P., Rifai N., et al. Ability of minor elevations of troponins I and T to predict benefit from an early invasive strategy in patients with unstable angina and non-ST-elevation myocardial infarction: results from a randomized trial. JAMA 286 (2001) 2405-2412
60. Giannitsis E., Lehrke S., Wiegand U.K., et al. Risk stratification in patients with inferior acute myocardial infarction treated by percutaneous coronary interventions: the role of admission troponin T. Circulation 102 (2000) 2038-2044
61. Bavry A.A., Kumbhani D.J., Quiroz R., et al. Invasive therapy along with glycoprotein IIb/IIIa inhibitors and intracoronary stents improves survival in non-ST-segment elevation acute coronary syndromes: a meta-analysis and review of the literature. Am J Cardiol 93 (2004) 830-835
62. Antman E.M. Troponin measurements in ischemic heart disease: more than just a black and white picture. J Am Coll Cardiol 38 (2001) 987-990
63. Horwich T.B., Patel J., MacLellan W.R., et al. Cardiac troponin I is associated with impaired hemodynamics, progressive left ventricular dysfunction, and increased mortality rates in advanced heart failure. Circulation 108 (2003) 833-838
64. Healey J.S., Davies R.F., Smith S.J., et al. Prognostic use of cardiac troponin T and troponin I in patients with heart failure. Can J Cardiol 19 (2003) 383-386
65. La Vecchia L., Mezzena G., Ometto R., et al. Detectable serum troponin I in patients with heart failure of nonmyocardial ischemic origin. Am J Cardiol 80 (1997) 88-90
66. Missov E., Calzolari C., and Pau B. Circulating cardiac troponin I in severe congestive heart failure. Circulation 96 (1997) 2953-2958
67. Liu Z., Cui L., Wang Y., et al. Cardiac troponin I and ventricular arrhythmia in patients with chronic heart failure. Eur J Clin Invest 36 (2006) 466-472
68. Nellessen U., Goder S., Schobre R., et al. Serial analysis of troponin I levels in patients with ischemic and nonischemic dilated cardiomyopathy. Clin Cardiol 29 (2006) 219-224
69. Jaffe A.S. Elevations in cardiac troponin measurements: false false-positives: the real truth. Cardiovasc Toxicol 1 (2001) 87-92
70. Lauer B., Niederau C., Kuhl U., et al. Cardiac troponin T in patients with clinically suspected myocarditis. J Am Coll Cardiol 30 (1997) 1354-1359
71. Smith S.C., Ladenson J.H., Mason J.W., et al. Elevations of cardiac troponin I associated with myocarditis. Experimental and clinical correlates. Circulation 95 (1997) 163-168
72. Del Carlo C.H., Pereira-Barretto A.C., Cassaro-Strunz C., et al. Serial measure of cardiac troponin T levels for prediction of clinical events in decompensated heart failure. J Card Fail 10 (2004) 43-48
73. Hudson M.P., O'Connor C.M., Gattis W.A., et al. Implications of elevated cardiac troponin T in ambulatory patients with heart failure: a prospective analysis. Am Heart J 147 (2004) 546-552
74. La Vecchia L., Mezzena G., Zanolla L., et al. Cardiac troponin I as diagnostic and prognostic marker in severe heart failure. J Heart Lung Transplant 19 (2000) 644-652
75. Setsuta K, Seino Y, Takahashi N, et al: Clinical significance of elevated levels of cardiac troponin T in patients with chronic heart failure. Am J Cardiol 1999;84:608-611, A9.
76. Sato Y., Yamada T., Taniguchi R., et al. Persistently increased serum concentrations of cardiac troponin t in patients with idiopathic dilated cardiomyopathy are predictive of adverse outcomes. Circulation 103 (2001) 369-374
77. Lee D.S., and Vasan R.S. Novel markers for heart failure diagnosis and prognosis. Curr Opin Cardiol 20 (2005) 201-210
78. Ishii J., Nomura M., Nakamura Y., et al. Risk stratification using a combination of cardiac troponin T and brain natriuretic peptide in patients hospitalized for worsening chronic heart failure. Am J Cardiol 89 (2002) 691-695
79. Douketis J.D., Crowther M.A., Stanton E.B., et al. Elevated cardiac troponin levels in patients with submassive pulmonary embolism. Arch Intern Med 162 (2002) 79-81
80. Giannitsis E., Muller-Bardorff M., Kurowski V., et al. Independent prognostic value of cardiac troponin T in patients with confirmed pulmonary embolism. Circulation 102 (2000) 211-217
81. Meyer T., Binder L., Hruska N., et al. Cardiac troponin I elevation in acute pulmonary embolism is associated with right ventricular dysfunction. J Am Coll Cardiol 36 (2000) 1632-1636
82. Muller-Bardorff M., Weidtmann B., Giannitsis E., et al. Release kinetics of cardiac troponin T in survivors of confirmed severe pulmonary embolism. Clin Chem 48 (2002) 673-675
83. Kucher N., Quiroz R., McKean S., et al. Extended enoxaparin monotherapy for acute symptomatic pulmonary embolism. Vasc Med 10 (2005) 251-256
84. Goldhaber S.Z., Visani L., and De Rosa M. Acute pulmonary embolism: clinical outcomes in the International Cooperative Pulmonary Embolism Registry (ICOPER). Lancet 353 (1999) 1386-1389
85. Kasper W., Konstantinides S., Geibel A., et al. Prognostic significance of right ventricular afterload stress detected by echocardiography in patients with clinically suspected pulmonary embolism. Heart 77 (1997) 346-349
86. Konstantinides S., Geibel A., Olschewski M., et al. Importance of cardiac troponins I and T in risk stratification of patients with acute pulmonary embolism. Circulation 106 (2002) 1263-1268
87. Coma-Canella I., Gamallo C., Martinez Onsurbe P., et al. Acute right ventricular infarction secondary to massive pulmonary embolism. Eur Heart J 9 (1988) 534-540
88. Binder L., Pieske B., Olschewski M., et al. N-terminal pro-brain natriuretic peptide or troponin testing followed by echocardiography for risk stratification of acute pulmonary embolism. Circulation 112 (2005) 1573-1579
89. Lualdi J.C., and Goldhaber S.Z. Right ventricular dysfunction after acute pulmonary embolism: pathophysiologic factors, detection, and therapeutic implications. Am Heart J 130 (1995) 1276-1282
90. Mehta N.J., Jani K., and Khan I.A. Clinical usefulness and prognostic value of elevated cardiac troponin I levels in acute pulmonary embolism. Am Heart J 145 (2003) 821-825
91. Konstantinides S., Geibel A., Olschewski M., et al. Association between thrombolytic treatment and the prognosis of hemodynamically stable patients with major pulmonary embolism: results of a multicenter registry. Circulation 96 (1997) 882-888
92. Mullner M., Hirschl M.M., Herkner H., et al. Creatine kinase-MB fraction and cardiac troponin T to diagnose acute myocardial infarction after cardiopulmonary resuscitation. J Am Coll Cardiol 28 (1996) 1220-1225
93. Grubb N.R., Fox K.A., and Cawood P. Resuscitation from out-of-hospital cardiac arrest: implications for cardiac enzyme estimation. Resuscitation 33 (1996) 35-41
94. Dahl C.F., Ewy G.A., Warner E.D., et al. Myocardial necrosis from direct current countershock. Effect of paddle electrode size and time interval between discharges. Circulation 50 (1974) 956-961
95. Doherty P.W., McLaughlin P.R., Billingham M., et al. Cardiac damage produced by direct current countershock applied to the heart. Am J Cardiol 43 (1979) 225-232
96. Metcalfe M.J., Smith F., Jennings K., et al. Does cardioversion of atrial fibrillation result in myocardial damage. Br Med J (Clin Res Ed) 296 (1988) 1364
97. Neumayr G., Hagn C., Ganzer H., et al. Plasma levels of troponin T after electrical cardioversion of atrial fibrillation and flutter. Am J Cardiol 80 (1997) 1367-1369
98. Rao A.C., Naeem N., John C., et al. Direct current cardioversion does not cause cardiac damage: evidence from cardiac troponin T estimation. Heart 80 (1998) 229-230
99. Bonnefoy E., Chevalier P., Kirkorian G., et al. Cardiac troponin I does not increase after cardioversion. Chest 111 (1997) 15-18
100. Lund M., French J.K., Johnson R.N., et al. Serum troponins T and I after elective cardioversion. Eur Heart J 21 (2000) 245-253
101. Garre L., Alvarez A., Rubio M., et al. Use of cardiac troponin T rapid assay in the diagnosis of a myocardial injury secondary to electrical cardioversion. Clin Cardiol 20 (1997) 619-621
102. Gorenek B., Kudaiberdieva G., Goktekin O., et al. Detection of myocardial injury after internal cardioversion for atrial fibrillation. Can J Cardiol 20 (2004) 165-168
103. Fulda G., Brathwaite C.E., Rodriguez A., et al. Blunt traumatic rupture of the heart and pericardium: a ten-year experience (1979-1989). J Trauma 31 (1991) 167-172 [discussion 72-3]
104. Salim A., Velmahos G.C., Jindal A., et al. Clinically significant blunt cardiac trauma: role of serum troponin levels combined with electrocardiographic findings. J Trauma 50 (2001) 237-243
105. Adams J.E., Davila-Roman V.G., Bessey P.Q., et al. Improved detection of cardiac contusion with cardiac troponin I. Am Heart J 131 (1996) 308-312
106. Mair P., Mair J., Koller J., et al. Cardiac troponin T in the diagnosis of heart contusion. Lancet 338 (1991) 693
107. Ognibene A., Mori F., Santoni R., et al. Cardiac troponin I in myocardial contusion. Clin Chem 44 (1998) 889-890
108. Bertinchant J.P., Polge A., Mohty D., et al. Evaluation of incidence, clinical significance, and prognostic value of circulating cardiac troponin I and T elevation in hemodynamically stable patients with suspected myocardial contusion after blunt chest trauma. J Trauma 48 (2000) 924-931
109. Ferjani M., Droc G., Dreux S., et al. Circulating cardiac troponin T in myocardial contusion. Chest 111 (1997) 427-433
110. Edouard A.R., Felten M.L., Hebert J.L., et al. Incidence and significance of cardiac troponin I release in severe trauma patients. Anesthesiology 101 (2004) 1262-1268
111. Ammann P., Fehr T., Minder E.I., et al. Elevation of troponin I in sepsis and septic shock. Intensive Care Med 27 (2001) 965-969
112. Noble J.S., Reid A.M., Jordan L.V., et al. Troponin I and myocardial injury in the ICU. Br J Anaesth 82 (1999) 41-46
113. Kollef M.H., Ladenson J.H., and Eisenberg P.R. Clinically recognized cardiac dysfunction: an independent determinant of mortality among critically ill patients. Is there a role for serial measurement of cardiac troponin I?. Chest 111 (1997) 1340-1347
114. Spies C., Haude V., Fitzner R., et al. Serum cardiac troponin T as a prognostic marker in early sepsis. Chest 113 (1998) 1055-1063
115. Guest T.M., Ramanathan A.V., Tuteur P.G., et al. Myocardial injury in critically ill patients. A frequently unrecognized complication. JAMA 273 (1995) 1945-1949
116. Murphy J.T., Horton J.W., Purdue G.F., et al. Evaluation of troponin-I as an indicator of cardiac dysfunction after thermal injury. J Trauma 45 (1998) 700-704
117. Thiru Y., Pathan N., Bignall S., et al. A myocardial cytotoxic process is involved in the cardiac dysfunction of meningococcal septic shock. Crit Care Med 28 (2000) 2979-2983
118. Fernandes Jr. C.J., Akamine N., and Knobel E. Cardiac troponin: a new serum marker of myocardial injury in sepsis. Intensive Care Med 25 (1999) 1165-1168
119. Ammann P., Maggiorini M., Bertel O., et al. Troponin as a risk factor for mortality in critically ill patients without acute coronary syndromes. J Am Coll Cardiol 41 (2003) 2004-2009
120. ver Elst K.M., Spapen H.D., Nguyen D.N., et al. Cardiac troponins I and T are biological markers of left ventricular dysfunction in septic shock. Clin Chem 46 (2000) 650-657
121. Brett J., Gerlach H., Nawroth P., et al. Tumor necrosis factor/cachectin increases permeability of endothelial cell monolayers by a mechanism involving regulatory G proteins. J Exp Med 169 (1989) 1977-1991
122. Kumar A., Thota V., Dee L., et al. Tumor necrosis factor alpha and interleukin 1beta are responsible for in vitro myocardial cell depression induced by human septic shock serum. J Exp Med 183 (1996) 949-958
123. Bryant D., Becker L., Richardson J., et al. Cardiac failure in transgenic mice with myocardial expression of tumor necrosis factor-alpha. Circulation 97 (1998) 1375-1381
124. Krown K.A., Page M.T., Nguyen C., et al. Tumor necrosis factor alpha-induced apoptosis in cardiac myocytes. Involvement of the sphingolipid signaling cascade in cardiac cell death. J Clin Invest 98 (1996) 2854-2865
125. Fernandes C., Junior J., Iervolino M., et al. Interstitial myocarditis in sepsis. Am J Cardiol 74 (1994) 958
126. Cunnion R.E., Schaer G.L., Parker M.M., et al. The coronary circulation in human septic shock. Circulation 73 (1986) 637-644
127. Hinshaw L.B. Sepsis/septic shock: participation of the microcirculation: an abbreviated review. Crit Care Med 24 (1996) 1072-1078
128. Arlati S., Brenna S., Prencipe L., et al. Myocardial necrosis in ICU patients with acute non-cardiac disease: a prospective study. Intensive Care Med 26 (2000) 31-37
129. Boddin M., Van Bogaert A., and Dierick W. Catecholamines in blood and myocardial tissue in experimental subarachnoidal hemorrhage. Cardiology 58 (1973) 229-237
130. Nino A.F., Berman M.M., Gluck E.H., et al. Drug-induced left ventricular failure in patients with pulmonary disease. Endomyocardial biopsy demonstration of catecholamine myocarditis. Chest 92 (1987) 732-736
131. Van Vliet P.D., Burchell H.B., and Titus J.L. Focal myocarditis associated with pheochromocytoma. N Engl J Med 274 (1966) 1102-1108
132. Adiseshiah M., and Baird R.J. Correlation of the changes in diastolic myocardial tissue pressure and regional coronary blood flow in hemorrhagic and endotoxic shock. J Surg Res 24 (1978) 20-25
133. Cheitlin M.D., McAllister H.A., and de Castro C.M. Myocardial infarction without atherosclerosis. JAMA 231 (1975) 951-959
134. Apple F.S., Murakami M.M., Pearce L.A., et al. Predictive value of cardiac troponin I and T for subsequent death in end-stage renal disease. Circulation 106 (2002) 2941-2945
135. McLaurin M.D., Apple F.S., Voss E.M., et al. Cardiac troponin I, cardiac troponin T, and creatine kinase MB in dialysis patients without ischemic heart disease: evidence of cardiac troponin T expression in skeletal muscle. Clin Chem 43 (1997) 976-982
136. Frankel W.L., Herold D.A., Ziegler T.W., et al. Cardiac troponin T is elevated in asymptomatic patients with chronic renal failure. Am J Clin Pathol 106 (1996) 118-123
137. Li D., Keffer J., Corry K., et al. Nonspecific elevation of troponin T levels in patients with chronic renal failure. Clin Biochem 28 (1995) 474-477
138. Ooi D.S., Zimmerman D., Graham J., et al. Cardiac troponin T predicts long-term outcomes in hemodialysis patients. Clin Chem 47 (2001) 412-417
139. Dierkes J., Domrose U., Westphal S., et al. Cardiac troponin T predicts mortality in patients with end-stage renal disease. Circulation 102 (2000) 1964-1969
140. Wayand D., Baum H., Schatzle G., et al. Cardiac troponin T and I in end-stage renal failure. Clin Chem 46 (2000) 1345-1350
141. Mallamaci F., Zoccali C., Parlongo S., et al. Diagnostic value of troponin T for alterations in left ventricular mass and function in dialysis patients. Kidney Int 62 (2002) 1884-1890
142. Abbas N.A., John R.I., Webb M.C., et al. Cardiac troponins and renal function in nondialysis patients with chronic kidney disease. Clin Chem 51 (2005) 2059-2066
143. Lowbeer C., Ottosson-Seeberger A., Gustafsson S.A., et al. Increased cardiac troponin T and endothelin-1 concentrations in dialysis patients may indicate heart disease. Nephrol Dial Transplant 14 (1999) 1948-1955
144. Collinson P.O., Hadcocks L., Foo Y., et al. Cardiac troponins in patients with renal dysfunction. Ann Clin Biochem 35 (1998) 380-386
145. Ricchiuti V., Zhang J., and Apple F.S. Cardiac troponin I and T alterations in hearts with severe left ventricular remodeling. Clin Chem 43 (1997) 990-995
146. Hamwi S.M., Sharma A.K., Weissman N.J., et al. Troponin-I elevation in patients with increased left ventricular mass. Am J Cardiol 92 (2003) 88-90
147. Jeon D.S., Lee M.Y., Kim C.J., et al. Clinical findings in patients with cardiac troponin T elevation and end-stage renal disease without acute coronary syndrome. Am J Cardiol 94 (2004) 831-834
148. Roppolo L.P., Fitzgerald R., Dillow J., et al. A comparison of troponin T and troponin I as predictors of cardiac events in patients undergoing chronic dialysis at a Veteran's Hospital: a pilot study. J Am Coll Cardiol 34 (1999) 448-454
149. Kiuchi K., Nejima J., Takano T., et al. Increased serum concentrations of advanced glycation end products: a marker of coronary artery disease activity in type 2 diabetic patients. Heart 85 (2001) 87-91
150. Diris J.H., Hackeng C.M., Kooman J.P., et al. Impaired renal clearance explains elevated troponin T fragments in hemodialysis patients. Circulation 109 (2004) 23-25
151. Ooi D.S., and House A.A. Cardiac troponin T in hemodialyzed patients. Clin Chem 44 (1998) 1410-1416
152. Mockel M., Schindler R., Knorr L., et al. Prognostic value of cardiac troponin T and I elevations in renal disease patients without acute coronary syndromes: a 9-month outcome analysis. Nephrol Dial Transplant 14 (1999) 1489-1495
153. Muller-Bardorff M., Hallermayer K., Schroder A., et al. Improved troponin T ELISA specific for cardiac troponin T isoform: assay development and analytical and clinical validation. Clin Chem 43 (1997) 458-466
154. Van Lente F., McErlean E.S., DeLuca S.A., et al. Ability of troponins to predict adverse outcomes in patients with renal insufficiency and suspected acute coronary syndromes: a case-matched study. J Am Coll Cardiol 33 (1999) 471-478
155. Al Badr W., Mukherjee D., Kline-Rogers E., et al. Clinical association between renal insufficiency and positive troponin I in patients with acute coronary syndrome. Cardiology 102 (2004) 215-219
156. Apple F.S., Murakami M.M., Pearce L.A., et al. Multi-biomarker risk stratification of N-terminal pro-B-type natriuretic peptide, high-sensitivity C-reactive protein, and cardiac troponin T and I in end-stage renal disease for all-cause death. Clin Chem 50 (2004) 2279-2285
157. Khan N.A., Hemmelgarn B.R., Tonelli M., et al. Prognostic value of troponin T and I among asymptomatic patients with end-stage renal disease: a meta-analysis. Circulation 112 (2005) 3088-3096
158. deFilippi C., Wasserman S., Rosanio S., et al. Cardiac troponin T and C-reactive protein for predicting prognosis, coronary atherosclerosis, and cardiomyopathy in patients undergoing long-term hemodialysis. JAMA 290 (2003) 353-359